2 Hrs
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
2 Hrsالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
2 HrsReady to play
Ready to play
A study conducted at U.S. clinics involving 225 patients, whose average age was about 70, found that LDL (“bad”) cholesterol fell by an average of 46.8% within a year of starting inclisiran injections. The reduction was 55.4% among those who also took statins. The drug is injected under the skin when treatment begins, again after three months, and then every six months. It works by reducing production of a protein that helps the liver remove LDL cholesterol. The study did not determine whether patients can stop taking daily cholesterol medicines: it did not randomly compare those who continued taking them with those who stopped. Any changes to treatment depend on the patient’s condition, risk factors, and ability to tolerate the medicines.
Notice: This Is an AI-Generated Summary
Comments (0)